Can We Beat Cancer? AI, mRNA, and the Future of Living Longer | Longevity, Episode 2

In the second episode of this four-part series, Rubenstein delved into the breakthroughs in cancer detection and treatment, how artificial intelligence could transform prevention and early diagnosis, why cancer rates are rising among young adults, the role of mRNA vaccines in preventing and treating future cancers and the urgent challenges of health disparities and access to care. Disclosure David Rubenstein is a Trustee of Memorial Sloan Kettering Cancer Center David Rubenstein is a Director of Moderna, Inc. David Rubenstein is a Trustee Emeritus of Johns Hopkins Medicine (Source: Bloomberg)